BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 19755855)

  • 1. Amplification of chromosomal segment 4q12 in non-small cell lung cancer.
    Ramos AH; Dutt A; Mermel C; Perner S; Cho J; Lafargue CJ; Johnson LA; Stiedl AC; Tanaka KE; Bass AJ; Barretina J; Weir BA; Beroukhim R; Thomas RK; Minna JD; Chirieac LR; Lindeman NI; Giordano T; Beer DG; Wagner P; Wistuba II; Rubin MA; Meyerson M
    Cancer Biol Ther; 2009 Nov; 8(21):2042-50. PubMed ID: 19755855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct phenotypic differences associated with differential amplification of receptor tyrosine kinase genes at 4q12 in glioblastoma.
    Burford A; Little SE; Jury A; Popov S; Laxton R; Doey L; Al-Sarraj S; Jürgensmeier JM; Jones C
    PLoS One; 2013; 8(8):e71777. PubMed ID: 23990986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand-dependent platelet-derived growth factor receptor (PDGFR)-alpha activation sensitizes rare lung cancer and sarcoma cells to PDGFR kinase inhibitors.
    McDermott U; Ames RY; Iafrate AJ; Maheswaran S; Stubbs H; Greninger P; McCutcheon K; Milano R; Tam A; Lee DY; Lucien L; Brannigan BW; Ulkus LE; Ma XJ; Erlander MG; Haber DA; Sharma SV; Settleman J
    Cancer Res; 2009 May; 69(9):3937-46. PubMed ID: 19366796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KIT and platelet-derived growth factor receptor alpha tyrosine kinase gene mutations and KIT amplifications in human solid tumors.
    Sihto H; Sarlomo-Rikala M; Tynninen O; Tanner M; Andersson LC; Franssila K; Nupponen NN; Joensuu H
    J Clin Oncol; 2005 Jan; 23(1):49-57. PubMed ID: 15545668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation and expression of PDGFRA and KIT in malignant peripheral nerve sheath tumors, and its implications for imatinib sensitivity.
    Holtkamp N; Okuducu AF; Mucha J; Afanasieva A; Hartmann C; Atallah I; Estevez-Schwarz L; Mawrin C; Friedrich RE; Mautner VF; von Deimling A
    Carcinogenesis; 2006 Mar; 27(3):664-71. PubMed ID: 16357008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 4q12 amplicon in malignant peripheral nerve sheath tumors: consequences on gene expression and implications for sunitinib treatment.
    Zietsch J; Ziegenhagen N; Heppner FL; Reuss D; von Deimling A; Holtkamp N
    PLoS One; 2010 Jul; 5(7):e11858. PubMed ID: 20686603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme.
    Joensuu H; Puputti M; Sihto H; Tynninen O; Nupponen NN
    J Pathol; 2005 Oct; 207(2):224-31. PubMed ID: 16021678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplification of KIT, PDGFRA, VEGFR2, and EGFR in gliomas.
    Puputti M; Tynninen O; Sihto H; Blom T; Mäenpää H; Isola J; Paetau A; Joensuu H; Nupponen NN
    Mol Cancer Res; 2006 Dec; 4(12):927-34. PubMed ID: 17189383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The three receptor tyrosine kinases c-KIT, VEGFR2 and PDGFRα, closely spaced at 4q12, show increased protein expression in triple-negative breast cancer.
    Jansson S; Bendahl PO; Grabau DA; Falck AK; Fernö M; Aaltonen K; Rydén L
    PLoS One; 2014; 9(7):e102176. PubMed ID: 25025175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent deletion of CDKN2A and recurrent coamplification of KIT, PDGFRA, and KDR in fibrosarcoma of bone--an array comparative genomic hybridization study.
    Niini T; López-Guerrero JA; Ninomiya S; Guled M; Hattinger CM; Michelacci F; Böhling T; Llombart-Bosch A; Picci P; Serra M; Knuutila S
    Genes Chromosomes Cancer; 2010 Feb; 49(2):132-43. PubMed ID: 19862822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in personalized therapeutics in non-small cell lung cancer: 4q12 amplification, PDGFRA oncogene addiction and sunitinib sensitivity.
    Swanton C; Burrell RA
    Cancer Biol Ther; 2009 Nov; 8(21):2051-3. PubMed ID: 19816149
    [No Abstract]   [Full Text] [Related]  

  • 12. Fluorescence in situ hybridization analysis and immunophenotyping of c-Kit/PDGFRA and Bcl-2 expression in gastrointestinal stromal tumors.
    Orsenigo M; Brich S; Riva C; Conca E; Bertulli R; Dileo P; Gronchi A; Casali PG; Pierotti MA; Tamborini E; Pilotti S
    Anal Quant Cytol Histol; 2010 Aug; 32(4):225-33. PubMed ID: 21434524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal MET Amplification as a Determinant of Tyrosine Kinase Inhibitor Resistance in Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer.
    Lai GGY; Lim TH; Lim J; Liew PJR; Kwang XL; Nahar R; Aung ZW; Takano A; Lee YY; Lau DPX; Tan GS; Tan SH; Tan WL; Ang MK; Toh CK; Tan BS; Devanand A; Too CW; Gogna A; Ong BH; Koh TPT; Kanesvaran R; Ng QS; Jain A; Rajasekaran T; Yuan J; Lim TKH; Lim AST; Hillmer AM; Lim WT; Iyer NG; Tam WL; Zhai W; Tan EH; Tan DSW
    J Clin Oncol; 2019 Apr; 37(11):876-884. PubMed ID: 30676858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplification of the PDGFRA, KIT and KDR genes in glioblastoma: a population-based study.
    Nobusawa S; Stawski R; Kim YH; Nakazato Y; Ohgaki H
    Neuropathology; 2011 Dec; 31(6):583-8. PubMed ID: 21382095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis.
    Zhao X; Weir BA; LaFramboise T; Lin M; Beroukhim R; Garraway L; Beheshti J; Lee JC; Naoki K; Richards WG; Sugarbaker D; Chen F; Rubin MA; Jänne PA; Girard L; Minna J; Christiani D; Li C; Sellers WR; Meyerson M
    Cancer Res; 2005 Jul; 65(13):5561-70. PubMed ID: 15994928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different pattern of expression of cellular oncogenes in human non-small-cell lung cancer cell lines.
    Kiefer PE; Wegmann B; Bacher M; Erbil C; Heidtmann H; Havemann K
    J Cancer Res Clin Oncol; 1990; 116(1):29-37. PubMed ID: 1690210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for PDGFRA, PDGFRB and KIT deregulation in an NSCLC patient.
    Negri T; Casieri P; Miselli F; Orsenigo M; Piacenza C; Stacchiotti S; Bidoli P; Casali PG; Pierotti MA; Tamborini E; Pilotti S
    Br J Cancer; 2007 Jan; 96(1):180-1. PubMed ID: 17213828
    [No Abstract]   [Full Text] [Related]  

  • 18. [EGFR and HER2 gene expression status and their correlation in non-small cell lung cancer].
    Zeng X; Wu SF; Zhou WX; Li DJ; Gao J; Liang ZY; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2006 Jul; 35(7):398-402. PubMed ID: 17069674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased gene copy number of KIT and VEGFR2 at 4q12 in primary breast cancer is related to an aggressive phenotype and impaired prognosis.
    Johansson I; Aaltonen KE; Ebbesson A; Grabau D; Wigerup C; Hedenfalk I; Rydén L
    Genes Chromosomes Cancer; 2012 Apr; 51(4):375-83. PubMed ID: 22170730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of prognostic implications of HER-2/neu abnormalities in 345 stage I non-small cell carcinomas (NSCLC) and 207 stage I-III neuroendocrine tumours (NET) of the lung.
    Pelosi G; Del Curto B; Dell'Orto P; Pasini F; Veronesi G; Spaggiari L; Maisonneuve P; Iannucci A; Terzi A; Lonardoni A; Viale G
    Int J Cancer; 2005 Jan; 113(1):101-8. PubMed ID: 15386424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.